Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Monogram Biosciences, Inc. | 75,000 | reported | 17 Mar 2004 | tx 2+125,000 |
| Serina Therapeutics, Inc. | 20,000 | reported | 22 May 2026 | tx 4+70,000 |
| Jazz Pharmaceuticals plc | 18,687 | reported | 05 Mar 2019 | tx 104+296,690−232,934 |
| Vaxart, Inc. | 15,097 | reported | 16 Jun 2021 | tx 2+80,797 |
| PROTEIN DESIGN LABS INC/DE | 10,494 | reported | 07 May 2009 | tx 1+10,494 |
| Elicio Therapeutics, Inc. | 7,900 | reported | 19 May 2025 | tx 7+64,818 |
| LAVA Therapeutics NV | 0 | reported | 13 Nov 2025 | tx 3+33,390−43,390 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | PURCHASE | Serina Therapeutics, Inc. | 10,000 | 1.77 USD | |
| 22 May 2026 | PURCHASE | Serina Therapeutics, Inc. | 10,000 | 1.93 USD | |
| 13 Nov 2025 | OTHER | LAVA Therapeutics NV | 10,000 | — | |
| 13 Nov 2025 | OTHER | LAVA Therapeutics NV | 33,390 | 0.00 USD | deriv |
| 07 Nov 2025 | GRANT_AWARD | Serina Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 19 May 2025 | GRANT_AWARD | Elicio Therapeutics, Inc. | 7,900 | 0.00 USD | deriv |
| 13 Feb 2025 | GRANT_AWARD | LAVA Therapeutics NV | 33,390 | 0.00 USD | deriv |
| 14 Jan 2025 | GRANT_AWARD | Serina Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |
| 21 Nov 2024 | GRANT_AWARD | Elicio Therapeutics, Inc. | 4,100 | 0.00 USD | deriv |
| 28 Dec 2023 | GRANT_AWARD | Elicio Therapeutics, Inc. | 4,100 | 0.00 USD | deriv |
| 09 Jun 2022 | GRANT_AWARD | Elicio Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 16 Jun 2021 | GRANT_AWARD | Vaxart, Inc. | 15,097 | 0.00 USD | deriv |
| 08 Mar 2021 | GRANT_AWARD | Elicio Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 09 Feb 2021 | CONVERSION | Elicio Therapeutics, Inc. | 18,718 | 11.57 USD | |
| 09 Feb 2021 | CONVERSION | Elicio Therapeutics, Inc. | — | 0.00 USD | deriv |
| 25 Aug 2020 | GRANT_AWARD | Vaxart, Inc. | 65,700 | 0.00 USD | deriv |
| 05 Mar 2019 | TAX_WITHHOLDING | Jazz Pharmaceuticals plc | 302 | 135.82 USD | |
| 05 Mar 2019 | TAX_WITHHOLDING | Jazz Pharmaceuticals plc | 276 | 135.82 USD | |
| 28 Feb 2019 | GRANT_AWARD | Jazz Pharmaceuticals plc | 3,500 | 0.00 USD | |
| 28 Feb 2019 | GRANT_AWARD | Jazz Pharmaceuticals plc | 8,174 | 0.00 USD | deriv |
| 28 Feb 2019 | GRANT_AWARD | Jazz Pharmaceuticals plc | 576 | 0.00 USD | deriv |
| 26 Feb 2019 | TAX_WITHHOLDING | Jazz Pharmaceuticals plc | 230 | 127.76 USD | |
| 25 Feb 2019 | TAX_WITHHOLDING | Jazz Pharmaceuticals plc | 310 | 126.25 USD | |
| 11 May 2018 | SALE | Jazz Pharmaceuticals plc | 3,706 | 165.00 USD | |
| 11 May 2018 | SALE | Jazz Pharmaceuticals plc | 54 | 165.01 USD | anomaly |